137 related articles for article (PubMed ID: 29758119)
1. Loss of protein phosphatase 6 in mouse keratinocytes enhances K-ras
Kurosawa K; Inoue Y; Kakugawa Y; Yamashita Y; Kanazawa K; Kishimoto K; Nomura M; Momoi Y; Sato I; Chiba N; Suzuki M; Ogoh H; Yamada H; Miura K; Watanabe T; Tanuma N; Tachi M; Shima H
Cancer Sci; 2018 Jul; 109(7):2178-2187. PubMed ID: 29758119
[TBL] [Abstract][Full Text] [Related]
2. PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features.
Fukui K; Nomura M; Kishimoto K; Tanuma N; Kurosawa K; Kanazawa K; Kato H; Sato T; Miura S; Miura K; Sato I; Tsuji H; Yamashita Y; Tamai K; Watanabe T; Yasuda J; Tanaka T; Satoh K; Furukawa T; Jingu K; Shima H
Cancer Sci; 2022 May; 113(5):1613-1624. PubMed ID: 35247012
[TBL] [Abstract][Full Text] [Related]
3. Ppp6c deficiency accelerates K-ras
Kishimoto K; Kanazawa K; Nomura M; Tanaka T; Shigemoto-Kuroda T; Fukui K; Miura K; Kurosawa K; Kawai M; Kato H; Terasaki K; Sakamoto Y; Yamashita Y; Sato I; Tanuma N; Tamai K; Kitabayashi I; Matsuura K; Watanabe T; Yasuda J; Tsuji H; Shima H
Cancer Med; 2021 Jul; 10(13):4451-4464. PubMed ID: 34145991
[TBL] [Abstract][Full Text] [Related]
4. ROCK2/ras
Masre SF; Rath N; Olson MF; Greenhalgh DA
Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.
Hayashi K; Momoi Y; Tanuma N; Kishimoto A; Ogoh H; Kato H; Suzuki M; Sakamoto Y; Inoue Y; Nomura M; Kiyonari H; Sakayori M; Fukamachi K; Kakugawa Y; Yamashita Y; Ito S; Sato I; Suzuki A; Nishio M; Suganuma M; Watanabe T; Shima H
Oncogene; 2015 Aug; 34(35):4647-55. PubMed ID: 25486434
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic K-Ras
Ito M; Tanuma N; Kotani Y; Murai K; Kondo A; Sumiyoshi M; Shima H; Matsuda S; Watanabe T
FEBS Open Bio; 2024 Apr; 14(4):545-554. PubMed ID: 38318686
[TBL] [Abstract][Full Text] [Related]
7. Loss of protein phosphatase 6 in mouse keratinocytes increases susceptibility to ultraviolet-B-induced carcinogenesis.
Kato H; Kurosawa K; Inoue Y; Tanuma N; Momoi Y; Hayashi K; Ogoh H; Nomura M; Sakayori M; Kakugawa Y; Yamashita Y; Miura K; Maemondo M; Katakura R; Ito S; Sato M; Sato I; Chiba N; Watanabe T; Shima H
Cancer Lett; 2015 Sep; 365(2):223-8. PubMed ID: 26054846
[TBL] [Abstract][Full Text] [Related]
8. Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.
Wang Z; Feng Y; Bardeesy N; Wong KK; Liu XY; Ji H
PLoS One; 2012; 7(5):e37308. PubMed ID: 22606359
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
10. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
11. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.
Raimondi AR; Molinolo A; Gutkind JS
Cancer Res; 2009 May; 69(10):4159-66. PubMed ID: 19435901
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
[TBL] [Abstract][Full Text] [Related]
14. The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors.
Sakamoto K; Lin B; Nunomura K; Izawa T; Nakagawa S
Sci Rep; 2022 May; 12(1):8121. PubMed ID: 35581303
[TBL] [Abstract][Full Text] [Related]
15. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.
Ichise T; Yoshida N; Ichise H
J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
17. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
[TBL] [Abstract][Full Text] [Related]
18. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
19. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
20. Does Mutated
Rice PFS; Ehrichs KG; Jones MS; Chen H; Hsu CH; Abril ER; Nagle RB; Besselsen DG; Barton JK; Ignatenko NA
Cancer Prev Res (Phila); 2018 Jan; 11(1):16-26. PubMed ID: 29118162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
